about
Mucous membrane pemphigoidA role for auto-immunity in chronic rhinosinusitis? Lessons learned from sub-epidermal bullous disorders of the skinPrevalence of pemphigus and pemphigoid autoantibodies in the general populationNeonatal Autoimmune Blistering Disease: A Systematic Review.Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled trial.Autoimmune blistering diseases in females: a review.Mechanisms of Autoantibody-Induced Pathology.Gestational pemphigoid.The era of the immunoglobulin A Fc receptor FcαRI; its function and potential as target in disease.Aberrant expression and secretion of heat shock protein 90 in patients with bullous pemphigoidBullous pemphigoid in infants: characteristics, diagnosis and treatment.Vitamin D and skeletal health in autoimmune bullous skin diseases: a case control studyBullous pemphigoid and neurological disease: statistics from a dermatology service.Activation of Blood Coagulation in Two Prototypic Autoimmune Skin Diseases: A Possible Link with Thrombotic Risk.Clinical presentation, pathogenesis, diagnosis, and treatment of epidermolysis bullosa acquisitaBullous pemphigoid and neurodegenerative diseases: a study in a setting of a Central European university dermatology departmentAldehyde dehydrogenase inhibition blocks mucosal fibrosis in human and mouse ocular scarring.Psychiatric and neurological disorders are associated with bullous pemphigoid - a nationwide Finnish Care Register study.Mucous membranepemphigoid in two half-sisters. The potential roles of autoantibodies to β4 integrin subunits and HLA-DQβ1*0301.Bullous pemphigoid: role of complement and mechanisms for blister formation within the lamina lucida.Inherited blistering skin diseases: underlying molecular mechanisms and emerging therapies.Hemorrhagic pustules in an Aboriginal man.BP180- and BP230-specific IgG autoantibodies in pruritic disorders of the elderly: a preclinical stage of bullous pemphigoid?Biopsy location for direct immunofluorescence in patients with suspected bullous pemphigoid impacts probability of a positive test result.Blistering disease: insight from the hemidesmosome and other components of the dermal-epidermal junction.Outcome measures for autoimmune blistering diseases.A gene network bioinformatics analysis for pemphigoid autoimmune blistering diseases.Immune mechanism-targeted treatment of experimental epidermolysis bullosa acquisita.IgE-mediated mechanisms in bullous pemphigoid and other autoimmune bullous diseases.Epidermolysis Bullosa Acquisita: From Pathophysiology to Novel Therapeutic Options.Discovering potential drug-targets for personalized treatment of autoimmune disorders - what we learn from epidermolysis bullosa acquisita.Macropinocytosis of type XVII collagen induced by bullous pemphigoid IgG is regulated via protein kinase C.Mechanisms of Disease: Pemphigus and Bullous Pemphigoid.Signalling and targeted therapy of inflammatory cells in epidermolysis bullosa acquisita.Bullous Pemphigoid: A Review of its Diagnosis, Associations and Treatment.Analysis of serum markers of cellular immune activation in patients with bullous pemphigoid.Four cases of mucous membrane pemphigoid with clinical features of oral lichen planus.Clinical features and diagnosis of epidermolysis bullosa acquisita.Management of patients with ocular manifestations in vesiculobullous disorders affecting the mouth.Hsp90 blockade modulates bullous pemphigoid IgG-induced IL-8 production by keratinocytes.
P2860
Q27691456-DE5A15EC-584F-4B9A-8461-FD7D9CFD3D5AQ28079094-46C18FF9-9270-46B9-8727-996F72DF173DQ28647292-8667D4D3-2967-42A5-A773-EFEC37903DABQ30251572-6295CF3A-E9E9-4843-9390-8D8D5E601CA5Q33592137-C1E6D743-6350-4456-93DD-0C6E1BF2861AQ33640302-26745DB6-19C8-490E-A4DC-111BCD585E21Q33740580-52D88C20-A854-4AB6-B137-3795DCF0D8E1Q34133053-05362FF8-1A22-4C5D-A96D-EE5C9A27371EQ34499286-C6762700-82E6-4757-AAC3-F7F5E3E7CD9BQ34923028-7BA6B8DD-252C-4176-B8C3-CC23EA7E95A6Q34998115-8C9F5812-01DB-40A6-AAFD-E66129A70F83Q35068151-BEA0612C-ACFE-42C4-B409-BA2FA8CC7CFFQ35211861-20DAA542-F09C-412C-91DB-B4714699232AQ35658142-6A1EF552-F76E-4F93-B7FC-5F4225D3D09DQ37055162-DF1FF8A7-B599-4A8D-B5A6-A6A9BE4B9EB8Q37059346-12AF1251-B81C-4645-9129-003443872033Q37277234-7D01257E-522B-4944-8396-FE2681343A6AQ37414075-752A0901-AC71-48D6-8460-008E3E861789Q37706638-E276B488-7A75-40E6-890B-8119AAF1107AQ38104810-10AB10B6-EB28-4F09-8C90-54326D67066FQ38180485-48B8038D-2DC3-4A88-9BF4-14B5BC3450CBQ38193020-82B1D9B2-979A-46B2-AF28-F92F5303A2BAQ38193888-F2A88B8A-B1AB-4035-8562-9113887D83F4Q38263099-D0094535-8510-4B78-AF6F-E47799014B52Q38287144-85F9666B-D5A1-4266-82BD-AB2D4E8BC5C5Q38307352-73FB8E4A-848C-438C-A325-52C27F05E1F6Q38470763-E2A898AC-E6AF-48AA-82B9-284B6AB27603Q38608315-9D606320-05F3-4FAA-B195-AFCDC2B21994Q38640323-FC5592D8-FF87-4535-910E-86855F2517EAQ38695599-EB5588BD-4D20-4E79-A029-E67302EFDF7DQ38720806-654C54C4-9007-49D0-BB6C-3E12398FED36Q38738038-1030D66A-EC8D-4D6F-B028-8261CB0818B2Q38747187-11934DDC-FD65-4CCB-BB71-368C614C14DEQ38749755-FBA799E7-08B0-4B2A-A8FC-EB9929FF671EQ38752194-D757B12D-0A5E-45A8-B315-96121F211E72Q38788350-C793BEA4-3C7C-40E9-BEFB-E5BEAD092912Q38837747-940C2CD8-41FA-49C2-8760-4945FC66200EQ38942490-6B484D72-FC79-4D5F-95FB-48E968E3E98AQ38975183-9CD180F7-F085-4FD0-A326-50F7FC253723Q38998547-C8DFA4E9-FCF4-4675-B5B3-29D9D5A13FDA
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Pemphigoid diseases.
@en
type
label
Pemphigoid diseases.
@en
prefLabel
Pemphigoid diseases.
@en
P1433
P1476
Pemphigoid diseases.
@en
P2093
Enno Schmidt
P304
P356
10.1016/S0140-6736(12)61140-4
P407
P577
2012-12-11T00:00:00Z